Non-Small Cell Lung Cancer/Mesothelioma/Thymomas and Thymic Carcinomas Panel - Disclosures
|
Panel Member
|
Dara Aisner MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Andrea Axtell MD, MPH |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Jessica Bauman MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Ankit Bharat MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Marian Birkeland PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Nicole Blankenhorn |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Joe Chang MD, PhD |
|
Grant/Research Support
|
| AstraZeneca Pharmaceuticals LP | Bristol Myers Squibb | Siemens Medical Solutions Diagnostics |
|
Date Completed
|
03/31/2025 |
|
Panel Member
|
Aakash Desai MD, MPH |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Thomas Dilling MD, MS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Jonathan Dowell MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Gregory Durm MD, MS |
|
Grant/Research Support
|
| Bristol Myers Squibb | Merck & Co., Inc. |
|
Date Completed
|
05/13/2025 |
|
Panel Member
|
Scott Gettinger MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kristina Gregory MSN, RN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Travis Grotz MD |
|
Grant/Research Support
|
| Intuitive Surgical, Inc. |
|
Date Completed
|
07/31/2024 |
|
Panel Member
|
Matthew Gubens MD, MS |
|
Grant/Research Support
|
| Amgen Inc. | Johnson & Johnson | Trizell |
|
Date Completed
|
07/29/2024 |
|
Panel Member
|
Evelyn Handel PharmD, BCOP, BCPS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Lisa Hang PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Laura Hanisch PsyD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kyle Herrmann BSN, RN, OCN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Brianna Herron PharmD, BCOP, BCPS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Erin Hesler |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Aditya Juloori MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Rudy Lackner MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Michael Lanuti MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Benjamin Levy MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Jules Lin MD, FACS |
|
Grant/Research Support
|
| Genentech |
|
Date Completed
|
06/08/2024 |
|
Panel Member
|
Billy Loo MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Christine Lovly MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Fabien Maldonado MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Daniel Morgensztern MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Trey Mullikin MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
John Murphy |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Thomas Ng MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Svitlana Ostanina PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Dwight Owen MD, MSc, FACP |
|
Grant/Research Support
|
| Bristol Myers Squibb | Genentech, Inc. | Merck & Co., Inc. | Onc.AI | Palobiofarma | Pfizer Inc. |
|
Date Completed
|
06/18/2024 |
|
Panel Member
|
Dawn Owen MD, PhD |
|
Grant/Research Support
|
| AstraZeneca Pharmaceuticals LP | Varian Medical Systems, Inc. |
|
Date Completed
|
12/23/2024 |
|
Panel Member
|
Sandip Patel MD |
|
Grant/Research Support
|
| Amgen, AstraZeneca, BeiGene, Bristol-Myers Squibb, Certis, Eli Lilly, Jazz, Genentech, Illumina , Merck, Pfizer, Signatera, Tempus |
|
Date Completed
|
01/26/2025 |
|
Panel Member
|
Tejas Patil MD |
|
Grant/Research Support
|
| Gilead Sciences, Inc. | Janssen Pharmaceutica Products, LP |
|
Date Completed
|
07/29/2024 |
|
Panel Member
|
Patricio Polanco MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Donna Powell DHSc, CMD, RT(T) |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Gregory Riely MD, PhD |
|
Grant/Research Support
|
| Amgen Inc. | Bristol Myers Squibb | Eli Lilly and Company | Merck & Co., Inc. | Novartis Pharmaceuticals Corporation | Pfizer Inc. | Roche Laboratories, Inc. | Takeda Pharmaceuticals North America, Inc. |
|
Date Completed
|
03/13/2025 |
|
Panel Member
|
Jonathan Riess MD, MS |
|
Grant/Research Support
|
| Arrivent | AstraZeneca Pharmaceuticals LP | IO Biotech | Kinnate | Merck & Co., Inc. | Novartis Pharmaceuticals Corporation | Nuvalent | Revolution Medicines | SeaGen | Summit |
|
Date Completed
|
07/10/2024 |
|
Panel Member
|
Ana Lucia Ruano Mendez MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Theresa Shapiro MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Aditi Singh MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
James Stevenson MD |
|
Grant/Research Support
|
| Alpha Oncology | AstraZeneca Pharmaceuticals LP | Black Diamond Therapeutics | Merck & Co., Inc. |
|
Date Completed
|
08/07/2024 |
|
Panel Member
|
Alda Tam MD |
|
Grant/Research Support
|
| Boston Scientific Corporation | Johnson & Johnson |
|
Date Completed
|
03/25/2025 |
|
Panel Member
|
Tawee Tanvetyanon MD, MPH |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Douglas Wood MD, FACS, FRCSEd |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Jane Yanagawa MD |
|
Ownership/Partnership/Principal
|
| ICONA |
|
Date Completed
|
04/08/2025 |
|
Panel Member
|
Edwin Yau MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
